Used in organic synthesis as a key intermediate for the development of pharmaceuticals, particularly in the creation of kinase inhibitors. It plays a significant role in Suzuki-Miyaura cross-coupling reactions, enabling the formation of carbon-carbon bonds in complex molecules. This compound is also utilized in the design of proteolysis targeting chimeras (PROTACs), which are innovative therapeutic agents for targeted protein degradation. Additionally, it finds application in the research and development of boron-based drugs, leveraging its boronic acid moiety for binding to biological targets. Its structural features make it valuable in medicinal chemistry for optimizing drug candidates with improved potency and selectivity.